Clinical Trial

Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC

Study acronym: TARGET-02
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 10, 2025 (before its estimated April 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Standard Maintenance Therapy versus Local Consolidative Radiation Therapy and standard maintenance therapy in 1-5 sites of OligoMetastatic Non-small cell lung cancer (NSCLC): A Phase III Randomized Controlled Trial
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-03-11; most recent amendment 2025-09-03.
Trial Details
NCT Number NCT05278052
Lead Sponsor Tata Memorial Hospital
Conditions Oligometastatic Disease, Metastatic Non Small Cell Lung Cancer
Enrollment 190 participants
Start Date 2020-04-20
Primary Completion 2026-04-20 (estimated)
Study Completion 2028-04-20 (estimated)
Updated on ClinicalTrials.gov 2025-09-10